Skip to content

Clinical trials

Phase 3 Coronary Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 3 Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20042
20052
20065
20071
20085
20095
20112
20121
20191
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott5
Hoffmann-La Roche3
Amgen2
GlaxoSmithKline2
Kastle Therapeutics, LLC2
National Heart, Lung, and Blood Institute (NHLBI)2
Pfizer2
University of California, San Francisco2
AbbVie (prior sponsor, Abbott)1
Abbott Medical Devices1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease34
Cardiovascular Diseases11
Heart Diseases9
Dyslipidemias8
Atherosclerosis6
Coronary Artery Disease6
Hypercholesterolemia5
Diabetes Mellitus4
Acute Coronary Syndrome3
Myocardial Infarction3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.